Literature DB >> 2453528

Beta-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy.

Y Kato1, G D Braunstein.   

Abstract

A small mol wt fragment of the beta-subunit of hCG (beta-core fragment) is present in the urine, but not the serum, of pregnant women. We evaluated the relative proportions of this immunoreactive, but biologically inactive, fragment in urine from 15 women at different stages of pregnancy. Freshly voided urine was ultrafiltered and concentrated, and the molecular species of immunoreactive hCG were separated by Sephadex G-100 column chromatography. All urine samples contained the beta-core fragment, which eluted after the alpha-subunit of hCG. This fragment lacked the carboxy-terminal epitope of hCG, was inactive as an in vitro bioassay, and adsorbed to Concanavalin-A. The beta-core fragment was a major form the immunoreactive hCG in urine throughout pregnancy and accounted for over 90% of the immunoreactive hCG in urine from midpregnancy. The excretion pattern of the beta-core fragment can account for the low biological to immunological ratio of urinary hCG that occurs at different stages of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453528     DOI: 10.1210/jcem-66-6-1197

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Negative urine pregnancy test in a molar pregnancy: is it possible?

Authors:  Aruna Nigam; Archana Kumari; Nidhi Gupta
Journal:  BMJ Case Rep       Date:  2014-11-05

2.  HLH beta core fragment immunoreactivity in the urine of ovulating women: a sensitive and specific immunometric assay for its detection.

Authors:  G Kovalevskaya; S Birken; J O'Connor; J Schlatterer; Y Maydelman; R Canfield
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

Review 3.  Human chorionic gonadotrophin and sport.

Authors:  A T Kicman; R V Brooks; D A Cowan
Journal:  Br J Sports Med       Date:  1991-06       Impact factor: 13.800

4.  Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.

Authors:  L A Cole; J H Nam
Journal:  Yale J Biol Med       Date:  1989 Jul-Aug

5.  Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine 'normal' and malignant epithelial cells.

Authors:  R K Iles; P E Purkis; P C Whitehead; R T Oliver; I Leigh; T Chard
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

6.  Urinary gonadotropin peptide (UGP) in Egyptian patients with benign and advanced malignant urological disease.

Authors:  O el-Ahmady; A B Halim; O Mansour; T Salman; A G el-Din; R P Walker
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

7.  Characterisation of UGP and its relationship with beta-core fragment.

Authors:  A Kardana; K D Bagshawe; B Coles; D Read; M Taylor
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

8.  Molecular forms of human chorionic gonadotropin in choriocarcinoma serum and urine.

Authors:  R Nishimura; T Kitajima; K Hasegawa; K Takeuchi; M Mochizuki
Journal:  Jpn J Cancer Res       Date:  1989-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.